Equity-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2019

Share-based Payment Arrangement, Noncash Expense [Abstract]

Schedule Of Number Of Awards And Weighted Average Grant Date Fair Value

The following table sets forth the number of equity-based awards granted during the nine months ended September 30, which will convert to shares upon vesting, along with the weighted average grant date fair values:

	2019			2018
Awards	Number of Awards (1)	Weighted Average Grant Date Fair Value		Number of Awards (2)	Weighted Average Grant Date Fair Value
Performance stock units	183,908	$	40.49	135,540	$	33.60
Restricted stock units	144,172	$	39.43	95,674	$	36.81
Deferred stock units	7,509	$	37.95	10,255	$	35.96
Common shares	7,509	$	37.95	2,113	$	35.50

(1) Included in the performance stock units granted above are 145,420 performance stock units awarded in the first quarter of 2019, which will convert to shares based on the Company's actual return on invested capital ("ROIC") relative to the ROIC targeted for the performance period ended December 31, 2019, and 38,488 performance stock units granted in the third quarter of 2019, which will convert to shares based on net sales and gross profit performance of Apeks acquired in August 2019 compared to targeted net sales and gross profit for the performance period ended December 31, 2021.

(2) Performance stock units granted in 2018 which will convert to 126,337 shares to be issued in the first quarter of 2021, representing 95.5% of the targeted 2018 award, based on the Company’s actual ROIC compared to ROIC target for the performance period ended December 31, 2018.

Management Stock Purchase Plan

The following table provides the number of restricted stock units credited to active participant accounts and the payments made with respect to restricted stock units issued under the MSPP during the nine months ended September 30,:

	2019		2018
Restricted stock units credited	51,381		74,180
Share-based liabilities paid (in thousands)	$	5,742	$	4,986